News

Sopheon has announced that Ciba, a manufacturer of specialty chemicals, has implemented the company’s Accolade product portfolio and innovation process management system to support its global initiative aimed

For the fiscal year ended December 31, 2008, net income totaled $1.83 million, or $0.11 per diluted share, compared to $2.24 million, or $0.13 per diluted share, for

For the 12 months ended December 31, 2008, the company reported a net loss of $13.16 million, or $0.31 per share, compared to a net loss of $41.46

For the year ended December 31, 2008, net loss was $44.7 million, or $1.51 per share, compared to a net loss of $43.7 million, or $1.60 per share,

Roche and Genentech, a biotechnology company, have signed a merger agreement under which Roche will acquire the outstanding publicly held interest in Genentech for $95 per share in

An EUA authorizes the use of unapproved medical products or unapproved uses of approved medical products during a declared public health emergency. “The FDA worked quickly with the

“Dave brings to Med BioGene over twenty years of experience in funding and operating life science companies. We are on track to launch LungExpress Dx(TM) in the second

PolyMedix, a biotechnology company, has successfully completed its first-in-man clinical study with the novel heparin antagonist drug PMX-60056. This ascending single-dose intravenous pharmacokinetic and safety study met the

Under the agreement, the three parties will jointly conduct a series of biomarker discovery studies for heart disease and early detection of metabolic syndrome – a combination of